These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29534234)

  • 1. Cost-effectiveness of hydrotherapy versus land-based therapy in patients with musculoskeletal disorders in Singapore.
    Teng M; Zhou HJ; Lin L; Lim PH; Yeo D; Goh S; Tjan SY; Lim BP
    J Public Health (Oxf); 2019 Jun; 41(2):391-398. PubMed ID: 29534234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial.
    Fernandes L; Roos EM; Overgaard S; Villadsen A; Søgaard R
    BMC Musculoskelet Disord; 2017 Jan; 18(1):5. PubMed ID: 28061841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manual therapy, exercise therapy, or both, in addition to usual care, for osteoarthritis of the hip or knee. 2: economic evaluation alongside a randomized controlled trial.
    Pinto D; Robertson MC; Abbott JH; Hansen P; Campbell AJ;
    Osteoarthritis Cartilage; 2013 Oct; 21(10):1504-13. PubMed ID: 23811491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Economic Impact of Acetabular Labral Tears: A Cost-effectiveness Analysis Comparing Hip Arthroscopic Surgery and Structured Rehabilitation Alone in Patients Without Osteoarthritis.
    Lodhia P; Gui C; Chandrasekaran S; Suarez-Ahedo C; Dirschl DR; Domb BG
    Am J Sports Med; 2016 Jul; 44(7):1771-80. PubMed ID: 27190068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.
    Moore A; Phillips C; Hunsche E; Pellissier J; Crespi S
    Pharmacoeconomics; 2004; 22(10):643-60. PubMed ID: 15244490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of economic models for cost effectiveness of physiotherapy interventions following total knee and hip replacement.
    Fatoye F; Gebrye T; Fatoye C; Mbada C
    Physiotherapy; 2022 Sep; 116():90-96. PubMed ID: 35605563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis.
    Epps H; Ginnelly L; Utley M; Southwood T; Gallivan S; Sculpher M; Woo P
    Health Technol Assess; 2005 Oct; 9(39):iii-iv, ix-x, 1-59. PubMed ID: 16181565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of health coaching and financial incentives to promote physical activity after total knee replacement.
    Smith KC; Paltiel AD; Yang HY; Collins JE; Katz JN; Losina E
    Osteoarthritis Cartilage; 2018 Nov; 26(11):1495-1505. PubMed ID: 30092263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness Modeling of Repetitive Transcranial Magnetic Stimulation Compared to Electroconvulsive Therapy for Treatment-Resistant Depression in Singapore.
    Zhao YJ; Tor PC; Khoo AL; Teng M; Lim BP; Mok YM
    Neuromodulation; 2018 Jun; 21(4):376-382. PubMed ID: 29143405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of accelerated perioperative care and rehabilitation after total hip and knee arthroplasty.
    Larsen K; Hansen TB; Thomsen PB; Christiansen T; Søballe K
    J Bone Joint Surg Am; 2009 Apr; 91(4):761-72. PubMed ID: 19339559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
    Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
    Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inconsistencies in NICE guidance for acupuncture: reanalysis and discussion.
    Latimer NR; Bhanu AC; Whitehurst DG
    Acupunct Med; 2012 Sep; 30(3):182-6. PubMed ID: 22759903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome.
    Zhao YJ; Khoo AL; Lin L; Teng M; Wu TS; Chan MY; Lim BP
    Value Health Reg Issues; 2016 May; 9():22-27. PubMed ID: 27881255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study.
    Xie F; Lo NN; Tarride JE; O'Reilly D; Goeree R; Lee HP
    Eur J Health Econ; 2010 Feb; 11(1):27-34. PubMed ID: 19430952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery.
    Mahmoudi M; Sobieraj DM
    Pharmacotherapy; 2013 Dec; 33(12):1333-40. PubMed ID: 23625693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.